Humanigen Inc (HGENQ)

[cowtown jay]

ZoomLenz . 2 of 2 . Synopsis. Topical Focus on Top Ihub>>Twitter posts

Subject: Market Opportunity

Note: I think I need to look more closely at Acute GvHD. This could be the dark horse winner of lenzilumab's first authorization or approval. Partnership interest. TeraImmune TReg work. Phase 2/3 trial.

"There will be a plethora of indications for lenz once it is approved and becomes known to the medical community. Add to that HGEN005...and ifabotuzumab..."


"Gilead's Magrolimab strikes out as blood cancer treatment...azacitidine..."

"If Gilead is scrapping their late-stage study of magrolimab with azacitidine to treat blood cancer, I wonder how that bodes for the other half dozen or so trials using that drug combination."


"The United States represents 4.23% of the world's population.
US percentage of (covid) cases 15.3%
US percentage of (covid) deaths 16.3%

It doesn't have to be that way, not when products from Humanigen, Novavax, Janssen, and Innovation, may stand ready to be used as components of a real vaccine cocktail."


"When we were naively thinking that LIVE-AIR's phenomenally successful trial outcome would result in an EUA, and could yield a market cap in the $20B range, we had reason to think that...Novavax had attained that level."

"I expect that we will benefit far more without a Gilead alliance...keep away from large market cap entities, and let the shareholders be the beneficiaries of the company's success."

"...valuation will prove far too low as the medical community becomes familiar with the value of lenzilumab's unique method of action."

Subject: Stock Play

"...our float is 229,164,012 shares, which is 192.45% of our 119,080,135 issued share total...Failures to Deliver (FTD's). Do we really want to issue additional shares for that purpose? Or do we just want paid to close out those open positions?"

"I wouldn't be surprised if we were actually under TWO business combination contracts, with PCI and with Baudax."

"Rule 204 Close-out Requirement. Rule 204 requires brokers and dealers that are participants of a registered clearing agency to take action to close out failure to deliver positions. Closing out requires the broker or dealer to purchase or borrow securities of like kind and quantity."

"I'm glad to see the Baudax/TeraImmune slide presentation features Recro staff as members of their Senior Management Team."

"I think a stock split is going to require that ALL shares outstanding be split 5:1. Illegal shorts will have to deliver 5 shares for every 1 they shorted."

"...the float of 229,164,012 was 192.45% of our current OS...So that's 110M shares more in the float, than in the OS."

"I should also consider that PCI Pharma may still be a targeted business combination."

"Baudax investment. It looks like we may have played a major role in financing their acquisition of TeraImmune by buying those 500K shares..."

"Why would we have funded Baudax's acquisition of TeraImmune, if we did not plan to merge with them?"

"I don't know what management's plan is in regards to Failures to Deliver, but I'm glad they are astute enough to manage this situation themselves..."

"less Ihub access to HGEN information...No information is provided on Shares in Issue or Float."

Subject: Influences

"I never understood why Hohneker and Xie were appointed to the board..."

"I don't (want) my taxpayer dollars to provide funding to Pfizer, if they are interfering with lenzilumab's authorization to prevent millions of deaths that their covid vaccines won't save."

"I hope Geert continues to communicate in videos.

But his comments regarding poor projected outcomes starting late this season, or early next season, for twice re-infected covid patients, is ominous."

""How is resigning at the same time, causing a Nasdaq non-conformance for the company, the faithful execution of their obligated Duty of Care?"

Initial "ZoomLenz" post

"Hohneker and Xie joined the BOD at the same time, and resigned on consecutive days."

"I think proof of our sabotage is in evidence already.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169869278
LIVE-AIR only included patients in disease severity scales 4 or 5. ACTIV-5 included patients in disease severity scales 5, 6, and 7."